IM Cannabis Closes US$1.31 Million Direct Share Offering Amid Financial Strain
TipRanks (Fri, 25-Sep 5:00 PM ET)
Market Chameleon (Fri, 25-Sep 7:51 AM ET)
IM Cannabis Raises US$1.31 Million in Hardship Financing With Related-Party Participation
TipRanks (Thu, 24-Sep 4:33 PM ET)
IM Cannabis Announces Closing of US$1.31 Million Registered Direct Offering of Common Shares
PRNewswire (Thu, 24-Sep 4:01 PM ET)
IM Cannabis Regains Nasdaq Compliance as Shares Meet Minimum Bid Threshold
TipRanks (Wed, 23-Sep 4:40 PM ET)
IM Cannabis regains Nasdaq compliance
Seeking Alpha News (Wed, 23-Sep 4:11 PM ET)
IM Cannabis Regains Compliance with Nasdaq Minimum Bid Price Requirement
PRNewswire (Wed, 23-Sep 4:01 PM ET)
IM Cannabis Raises US$1.31 Million in Direct Share Offering Amid Financial Strain
TipRanks (Wed, 23-Sep 10:10 AM ET)
IM Cannabis prices $1.31M registered direct offering
Seeking Alpha News (Wed, 23-Sep 9:24 AM ET)
IM Cannabis Announces Pricing of US$1.31 Million Registered Direct Offering of Common Shares
PRNewswire (Wed, 23-Sep 8:38 AM ET)
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority revenue is generated from Germany, and also has its presence in Israel.
Im Cannabis Corp. - Common Shares trades on the NASDAQ stock market under the symbol IMCC.
As of September 25, 2026, IMCC stock price declined to $2.84 with 412,405 million shares trading.
IMCC has a beta of 1.08, meaning it tends to be more sensitive to market movements. IMCC has a correlation of 0.01 to the broad based SPY ETF.
IMCC has a market cap of $1.72 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, IMCC traded as high as $243.00 and as low as $1.55.
IMCC has underperformed the market in the last year with a return of -94.7%, while the SPY ETF gained +18.4%. In the last 3 month period, IMCC fell short of the market, returning -32.9%, while SPY returned +5.3%. However, in the most recent 2 weeks IMCC has outperformed the stock market by returning +62.3%, while SPY returned +1.2%.
IMCC support price is $2.71 and resistance is $3.66 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IMCC shares will trade within this expected range on the day.